Last updated on May 2019

A Phase 2, Open-Label, 2-Cohort Study of INCB050465, a PI3K-delta Inhibitor, in Subjects With Relapsed or Refractory Marginal Zone Lymphoma With or Without Prior Exposure to a BTK Inhibitor (CITADEL-204)


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of two INCB050465 treatment regimens in participants diagnosed with relapsed or refractory marginal zone lymphoma (MZL) who are naive to or were previously treated with a Bruton's tyrosine kinase (BTK) inhibitor.

 

Clinical Study Identifier: TX203807

Find a site near you

Start Over

Henry Ford Hospital

Located in: Detroit, MI USA
  Connect »

Seattle Cancer Care Alliance

Located in: Seattle, WA USA
  Connect »

Clinical Research Alliance

Located in: Lake Success, NY USA
  Connect »

Clinical Trials of SWLA, LLC

Located in: Lake Charles, LA USA
  Connect »

Rush University Medical Center

Located in: Chicago, IL USA
  Connect »

Asclepes Research Centers

Located in: Brooksville, FL USA
  Connect »

Arizona Oncology

Located in: Phoenix, AZ USA
  Connect »

Gettysburg Cancer Center

Located in: Gettysburg, PA USA
  Connect »

Mission Hope Cancer Center

Located in: Santa Maria, CA USA
  Connect »

St. Mary's Medical Center

Located in: Grand Junction, CO USA
  Connect »

Sansum Clinic

Located in: Santa Barbara, CA USA
  Connect »

Renovatio Clinical

Located in: Houston, TX USA
  Connect »

Calvary North Adelaide Hospital

Located in: North Adelaide, Australia
  Connect »

Icon Cancer Foundation

Located in: South Brisbane, Australia
  Connect »

The Chaim Sheba Medical Center

Located in: Ramat Gan, Israel
  Connect »

Tel Aviv Sourasky Medical Center

Located in: TEL AVIV-YAFO, Israel
  Connect »

Hadassah Ein Karem Hospital

Located in: Jersusalem, Israel
  Connect »

Hosp Universitario Salamanca

Located in: Salamanca, Spain
  Connect »

Hospital Quirón Madrid

Located in: Madrid, Spain
  Connect »

Birmingham Heartlands Hospital

Located in: Birmingham, United Kingdom
  Connect »

Kent Oncology Centre

Located in: Maidstone, United Kingdom
  Connect »

UZ LEUVEN

Located in: Leuven, Belgium
  Connect »

SAINT LUKE'S HOSPITAL OF KANSAS CITY

Located in: Kansas City, MO USA
  Connect »

AALBORG UNIVERSITY HOSPITAL

Located in: Aalborg, Denmark
  Connect »

ZEALAND UNIVERSITY HOSPITAL

Located in: Roskilde, Denmark
  Connect »

RAMBAM MEDICAL CENTER

Located in: Haifa, Israel
  Connect »

HOSPITAL DURAN I REYNALS

Located in: Barcelona, Spain
  Connect »

KLINIKUM LUDWIGSHAFEN

Located in: Ludwigshafen, Germany
  Connect »

AVICENNE HOSPITAL

Located in: Bobigny, France
  Connect »

UCLA HEALTHCARE

Located in: Santa Monica, CA USA
  Connect »

ROYAL ADELAIDE HOSPITAL

Located in: Adelaide, Australia
  Connect »

UNIVERSITATSKLINIKUM ULM

Located in: Ulm, Germany
  Connect »

UNIVERSITATSKLINIKUM ESSEN

Located in: Essen, Germany
  Connect »

MEDICAL COLLEGE OF WISCONSIN

Located in: MILWAUKEE, WI USA
  Connect »

SAPIENZA UNIVERSITY

Located in: ROME, Italy
  Connect »

CENTRE HENRI BECQUEREL

Located in: ROUEN, France
  Connect »

HOPITAL SAINT-LOUIS

Located in: PARIS, France
  Connect »

UNIVERSITÄTSMEDIZIN GÖTTINGEN

Located in: GÖTTINGEN, Germany
  Connect »

CENTRE HOSPITALIER LYON SUD

Located in: PIERRE-BÉNITE CEDEX, France
  Connect »

PRESIDIO OSPEDALIERO PESCARA

Located in: PESCARA, Italy
  Connect »

INSTITUTE GUSTAVE ROUSSY (IGR)

Located in: VILLEJUIF, France
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.